Clinical Research Detail Title Of Study The purpose of this study is to determine the effect of 2 different doses of daclizumab on reducing relapses in subjects with relapsing-remitting MS. Disease Condition Relapsing Remitting Multiple Sclerosis Phase of Trial Phase-2 Discipline Neurology Start date of Trial 2/1/2008 Closing Date of Trial 2/1/2012 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]